Long-term drug costs per life-month gained associated with first-line treatments for unresectable or metastatic melanoma.

Saved in:

Bibliographic Details
Title:	Long-term drug costs per life-month gained associated with first-line treatments for unresectable or metastatic melanoma.
Authors:	Liu, Jun S.¹, Rao, Sumati² Sumati.rao@bms.com
Source:	Experimental Hematology & Oncology. 4/11/2016, Vol. 5, p1-9. 9p.
Database:	Academic Search Ultimate

Description
ISSN:	21623619
DOI:	10.1186/s40164-016-0039-0